Wegovy, a drug similar to Ozempic, shocked researchers with an unexpected finding after a several-year-long study: The drug dropped death rates in those infected with COVID-19 and decreased deaths from any cause.
The drug is prescribed to those with obesity to aid in weight loss and aims to reduce the risk of cardiovascular events. Drugs like it, semaglutides, have grown increasingly popular.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.
